Open tenders for Mitem Pharma
630 open tenders fit what Mitem Pharma offers; 2,316 are in the categories where it won public tenders since 2024.
- Pharmaceutical products · 1 win
Tenders that fit what Mitem Pharma offers
Closest in meaning to its products: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest · Develops and commercializes essential and niche medicines for patients with serious conditions. Tenders in other languages match too. Best fit first, top 20 of 630.
Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Nilotinib (ATC-Code nach WHO: L01EA03)
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
Open-House-Rabattverträge 2026-13 Nintedanib
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
Arzneimittel mit dem Wirkstoff Nintedanib (ATC: L01EX09)
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
Arzneimittel mit dem Wirkstoff Nintedanib (ATC: L01EX09)
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
36. Generikaausschreibung (2/3er)
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
Amgros 2027 1.153.a
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu patentgeschützten Wirkstoffen-VV90
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V ab dem 01.07.2025
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Nintedanib (ATC-Code: L01EX09).
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V ab dem 01.12.2026
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu patentgeschützten Wirkstoffen-VV89
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V ab dem 01.09.2026
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
Arzneimittel mit dem Wirkstoff Eptinezumab (ATC: N02CD05)
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nitisinon, (OBO) ATC A16AX04 für die Zeit 01.03.2025 - 28.02.2027
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V Fachlos unbesetzt
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Trientin (ATC-Code nach WHO: A16AX12)
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
Open-House-Originale-Rabattverträge 2026-05 Alectinib
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
Arzneimittel mit dem Wirkstoff Nilotinib (ATC: L01EA03)
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
Amgros 2027 1.1153.a
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
Amgros 2027 2.590.b
Fits: Develops, acquires and commercializes essential, niche and neglected medicines, including medicines of major therapeutic interest
In the categories Mitem Pharma wins
Accord-cadre mono-attributaire à bons de commande relatif à la fourniture et livraison de produits de santé et à la gestion des déchets d'activités de soins à risques infectieux (DASRI) pour les centres de Protection Maternelle et Infantile (PMI) de la Collectivité de Saint-Martin
Substante si produse farmaceutice
Dodávka liekov a liečiv II.
Achizitionarea de medicamente
Roztok k výplachu močového měchýře s obsahem kyseliny hyaluronové
Achiziționarea medicamentelor pentru tratamentul Artritei juvenile în scopul realizării Programului Național „Combaterea maladiilor rare” pentru anul 2027
„Доставка на Darolutamide, заплащан от НЗОК извън цената на клиничните пътеки и процедури, за нуждите на "СБАЛОЗ д-р Марко A. Марков - Варна" ЕООД“
Amgros 2027 1.370.a
Dostawy leków
Dostawa leków cytostatycznych, w tym leków cytostatycznych niezbędnych do realizacji świadczeń z zakresu chemioterapii i programów lekowych dla potrzeb Beskidzkiego Centrum Onkologii – Szpitala Miejskiego im. Jana Pawła II w Bielsku – Białej
Przetarg nieograniczony - art. 132 Ustawy Prawo zamówień publicznych
Procedura aperta per l’affidamento mediante accordo quadro con più operatori economici della fornitura di farmaci, parafarmaci, SOP, OTC e di tutti i prodotti erogabili nel normale ciclo distributivo delle farmacie
Dostawy produktów leczniczych, żywności specjalnego przeznaczenia medycznego oraz wyrobów medycznych
Nakup farmacevtskih ovojnin
Fourniture de médicaments du système nerveux pour les Etablissements de santé de Bretagne
Dostawa leków
Sukcesywne dostawy produktów leczniczych oraz innych wyrobów medycznych w postaci pasków testowych do samodzielnej kontroli glukozy we krwi, wykorzystywanych przez członków ZRM.
Dostawa produktów do żywienia dojelitowego, pozajelitowego oraz wyrobów medycznych do podaży diet
Dostawa leków i środków dezynfekujących dla Zespołu Opieki Zdrowotnej w Skarżysku-Kamiennej
Dostawa leków stosowanych w programach lekowych
Léčivý přípravek s účinnou látkou OSIMERTINIB-MESILÁT
Léčivý přípravek s účinnou látkou IPILIMUMAB
Dostawa poliheksanidu w ramach Programu lekowego
Zakup wraz z dostawą leków ogólnych, diet dojelitowych i płynów infuzyjnych dla Apteki Szpitalnej Świętokrzyskiego Centrum Onkologii w Kielcach
Zakup i dostawa produktów leczniczych stosowanych w ramach programów lekowych, chemioterapii i poza programami z dostawą do trzech lokalizacji UCK WUM.